| Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological … B Simmons, J Saleem, K Heath, GS Cooke, A Hill Clinical Infectious Diseases 61 (5), 730-740, 2015 | 329 | 2015 |
| The Joint United Nations Programme on HIV/AIDS 95–95–95 targets: worldwide clinical and cost benefits of generic manufacture K Heath, J Levi, A Hill Aids 35 (Supplement 2), S197-S203, 2021 | 112 | 2021 |
| Minimum costs to manufacture new treatments for COVID-19 A Hill, J Wang, J Levi, K Heath, J Fortunak Journal of Virus Eradication 6 (2), 61-69, 2020 | 103 | 2020 |
| Effects of sustained virological response (SVR) on the risk of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 23,309 … AM Hill, J Saleem, KA Heath, B Simmons Hepatology 60, 218A-219A, 2014 | 60 | 2014 |
| Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries J Kempton, A Hill, JA Levi, K Heath, A Pozniak Journal of virus eradication 5 (2), 92-101, 2019 | 47 | 2019 |
| Higher risks of mother-to-child HIV transmission in countries with lower HIV prevalence: UNAIDS 2013 results for 32 countries with generalised epidemics A Hill, T Dauncey, J Levi, K Heath, CP Casas Journal of virus eradication 1 (4), 257-263, 2015 | 18 | 2015 |
| The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countries J Levi, A Pozniak, K Heath, A Hill Journal of virus eradication 4 (2), 80-90, 2018 | 16 | 2018 |
| Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia T Nguyen, AJ Thomas, P Kerr, AC Stewart, AL Wilkinson, L Nguyen, ... BMC Medical Research Methodology 23 (1), 54, 2023 | 11 | 2023 |
| WHO method for estimating congenital syphilis to inform surveillance and service provision, Paraguay K Heath, M Alonso, G Aguilar, T Samudio, E Korenromp, J Rowley, ... Bulletin of the World Health Organization 100 (3), 231, 2022 | 10 | 2022 |
| Intent to be vaccinated against COVID-19 in Victoria, Australia K Heath, A Altermatt, F Saich, A Pedrana, S Fletcher-Lartey, AL Bowring, ... Vaccines 10 (2), 209, 2022 | 10 | 2022 |
| Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C K Heath ClinicoEconomics and Outcomes Research, 539-550, 2018 | 9 | 2018 |
| Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV/syphilis rapid diagnostic tests in eleven high burden countries S Shah, S Garg, K Heath, O Ofili, Y Bansal, F Seghers, A Storey, M Taylor PLoS One 16 (8), e0256400, 2021 | 6 | 2021 |
| Nutritional availability and larval density dependence in Aedes aegypt K Heath, RS Paton, AJ Wilson, M Bonsall Ecological Entomology 45 (5), 2020 | 6 | 2020 |
| Keeping kids in school: modelling school-based testing and quarantine strategies during the COVID-19 pandemic in Australia RG Abeysuriya, R Sacks-Davis, K Heath, D Delport, FM Russell, ... Frontiers in Public Health 11, 1150810, 2023 | 5 | 2023 |
| Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture K Heath, J Levi, A Hill Available at SSRN 3696865, 2021 | 4 | 2021 |
| WHO hepatitis C elimination targets: the global equity challenge K Heath, A Hill The Lancet Gastroenterology & Hepatology 9 (4), 286-288, 2024 | 3 | 2024 |
| Mathematical modelling of the mosquito Aedes polynesiensis in a heterogeneous environment K Heath, MB Bonsall, J Marie, HC Bossin Mathematical Biosciences 348, 108811, 2022 | 3 | 2022 |
| I know what you did last summer: a cross-sectional study of personal COVID-19 risk reduction strategies used by Victorian adults, December 2021–January 2022 WC Tse, A Altermatt, F Saich, AL Wilkinson, K Heath, K Young, A Pedrana, ... Australian and New Zealand journal of public health 47 (3), 100068, 2023 | 2 | 2023 |
| The Joint United Nations Programme on HIV/AIDS 95–95–95 targets: worldwide clinical and cost benefits of generic manufacture J Levi, A Hill AIDS 35 (Supplement 2), S197, 2021 | 2 | 2021 |
| High probability of female-to-male HIV-1 transmission for uncircumcised men with multiple partners C Crabb AIDS 19 (10), N1, 2005 | 2 | 2005 |
